Skip to main content
LMRI
NASDAQ Industrial Applications And Services

Lumexa Q3: Net Income Turns Positive at $7.2M, Adjusted EPS Guidance Raised to $0.86-$0.90

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$13.92
Mkt Cap
$1.337B
52W Low
$6.45
52W High
$19.45
52W Position info
116% above low
Off High info
28% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

LMRI has more than doubled off its 52-week low of $6.45.

Summary

Lumexa reported Q3 2026 net income of $7.2 million versus a $3.5 million loss a year ago, with Adjusted EBITDA of $62.6 million. Full-year Adjusted EPS guidance rose to $0.86-$0.90 on a lower tax rate, while the Adjusted EBITDA range was merely narrowed around an unchanged $238 million midpoint.


Key Events · Earnings and Guidance · LMRI

  • Q3 Revenue Up 5.0% to $272.0M

    Consolidated revenue rose to $272.0 million from $258.9 million, with system-wide growth of 7.7% and advanced outpatient volume up 7.9% consolidated.

  • Net Income Turns Positive at $7.2M

    Net income of $7.2 million versus a $3.5 million net loss a year earlier; GAAP EPS of $0.07 and Adjusted EPS of $0.26. Interest expense fell to $15.7 million from $30.6 million.

  • Adjusted EPS Guidance Raised

    Full-year 2026 Adjusted EPS guidance lifted to $0.86-$0.90 from $0.71-$0.77, driven by a lower assumed effective tax rate rather than operating improvement.

  • EBITDA Range Narrowed, Midpoint Flat

    Adjusted EBITDA guidance narrowed to $236-$240 million from $235-$241 million, midpoint unchanged at $238 million; $7 million of new public-company costs cut 2026 growth to 4% from 7%.


Analysis · LMRI · Industrial Applications And Services

The swing from a $3.5 million net loss to $7.2 million of net income is the quarter's most striking line, helped by interest expense falling to $15.7 million from $30.6 million; nine-month operating cash flow also flipped to $70.5 million from roughly breakeven. Guidance is where the nuance sits. Adjusted EPS was raised to $0.86-$0.90 from $0.71-$0.77, but the driver is a lower assumed tax rate, not better operations. Adjusted EBITDA guidance was only narrowed to $236-$240 million, with the $238 million midpoint unchanged, and management notes that $7 million of new public-company costs cut 2026 Adjusted EBITDA growth to 4% from 7%. Revenue guidance of $1.045-$1.097 billion was reiterated, so the quarter reads as a solid, cash-generative confirmation rather than an upgrade to the operating story.

How filings like this one have moved

In the 30 days to Nov 11, 2026, 36.6% of the 3434 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, LMRI was trading at $13.92 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.3B. The 52-week trading range was $6.45 to $19.45. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

LMRI - Latest Insights

LMRI
Nov 10, 2026, 4:08 PM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $13.92
Real-time Price: $16.03 info
Change: +$2.11 (+15%) info
Market Cap: $1.54B info
LMRI
Aug 13, 2026, 2:54 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $12.30
Real-time Price: $16.03 info
Change: +$3.74 (+30%) info
Market Cap: $1.54B info
LMRI
Aug 12, 2026, 4:18 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $12.00
Real-time Price: $16.03 info
Change: +$4.03 (+34%) info
Market Cap: $1.54B info
LMRI
Aug 12, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $12.06
Real-time Price: $16.03 info
Change: +$3.97 (+33%) info
Market Cap: $1.54B info
LMRI
Jun 30, 2026, 5:13 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $11.28
Real-time Price: $16.03 info
Change: +$4.75 (+42%) info
Market Cap: $1.54B info